Bridging with enoxaparin using a half-therapeutic dose regimen: Safety and efficacy

Vasa - Journal of Vascular Diseases

Volumn 39, Issue 3, 2010, Pages 243-248

  Klamroth, Robert ^a   Gottstein, S ^a   Essers, E ^a   Landgraf, H ^a  

^a VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

Author keywords

Anticoagulation; Enoxaparin; Low molecular weight heparin; Perioperative therapy; Thromboembolism

Indexed keywords

ENOXAPARIN; PHENPROCOUMON; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLEEDING; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; PROSPECTIVE STUDY; THROMBOEMBOLISM; AGED; BLOOD; BLOOD CLOTTING; BLOOD LOSS, SURGICAL; CHEMICALLY INDUCED; DRUG EFFECTS; GERMANY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; POSTOPERATIVE HEMORRHAGE; REGISTER; RISK ASSESSMENT; RISK FACTOR; SURGERY; TIME; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; ENOXAPARIN; FEMALE; GERMANY; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PHENPROCOUMON; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; THROMBOEMBOLISM; TIME FACTORS;

EID: 77956605562     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000036     Document Type: Article

References (17)

1. Bauersachs R. M., Haas S., Thromboprophylaxis - Key points for the angiologist. VASA 2009 (38) 2: 135-46.
2. Bounameaux H., Righini M., Perrier A., Venous thromboembolism: Contemporary diagnostic and therapeutic aspects. VASA 2008 (37) 3: 211-26.
3. Boneu B, Caranobe C, Sie P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Haematol 1990; 3: 531-44.
4. Bonow RO, Carabello B, de Leon AC. ACC / AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 1998; 32: 1486-588.
5. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J. The perioperative management of antithrombotic therapy. 8th ACCP Consensus Conference on Antithrombotic Therapy. Chest 2008; 133 (suppl): 299S-339S.
6. Du Breuil AL, Umland EM. Outpatient Management of Anticoagulation Therapy. American Family Physician 2007; 75 (7): 1031-42.
7. Dunn A. Perioperative management of oral anticoagulation: when and how to bridge. J Thromb Thrombolysis 2006; 21 (1): 85-9.
8. Dunn AS, Spyropoulos AC, Turpie AGG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Perioperative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemos 2007; 5: 2211-8.
9. Ferreira I, Dos L, Tornos P, et al. Experience with Enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003; 89: 527-30.
10. Jaffer AK, Ahmed M, Brotman DJ, et al. Low-Molecular-Weight-Heparins as Periprocedural Anticoagulation for Patients on Long-Term Warfarin Therapy: A Standardized Bridging Therapy Protocol. J Thrombosis and Thrombolysis 2005; 20 (1): 11-6.
11. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336 (21): 1506-11.
12. Madura JA, Rookstool M, Wease G. The management of patients on chronic warfarin therapy undergoing subsequent procedures. Am Surg 1994; 60: 542-6.
13. O'Donnell MJ, Kearon C, Johnson J, et al. Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. Ann Intern Med. 2007; 146: 184-7.
14. Omran H, Hammerstingl C, Paar WD for the Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events. Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients. Med Klin 2007; 102: 809-15.
15. Spandorfer JM, Lynch S, Weitz HH, et al. Use of Enoxaparin for the Chronically Anticoagulated Patient Before and After Procedures. The American Journal of Cardiology 1999; 84 (15): 478-80.
16. Spyropoulos AC, Turpie AGG, Dunn AS, et al. for the REGIMEN Investigators. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006; 4: 1246-52.
17. Turpie AG, Douketis JD. Enoxaparin is effective and safe as bridging anticoagulation in patients with a mechanical prosthetic heart valve who require temporary interruption of warfarin because of surgery or an invasive procedure [Abstract]. Blood 2004; 104: 202A. Abstract no. 703.